Reference for FOSTEMSAVIR. Search for FOSTEMSAVIR

AI searches containing FOSTEMSAVIR

FOSTEMSAVIR

Fostemsavir

Antiretroviral medication used to treat HIV

Fostemsavir, sold under the brand name Rukobia, is an antiretroviral medication for adults living with HIV/AIDS who have tried multiple HIV medications

Fostemsavir

Drug of last resort

Type of drug

those caused by Pseudomonas; carries risk of kidney and nerve damage. Fostemsavir (an HIV attachment inhibitor) and lenacapavir (an HIV capsid inhibitor)

Drug of last resort

Drug_of_last_resort

Bristol Myers Squibb

American pharmaceutical company

(BMS-582664) – development terminated Elotuzumab (BMS-901608) – phase III Fostemsavir (BMS-663068) – approved in the United States in July 2020 Lirilumab (BMS-986015)

Bristol Myers Squibb

Bristol_Myers_Squibb

ViiV Healthcare

Pharmaceutical company

delavirdine (brand name Rescriptor, no longer available) Attachment inhibitors fostemsavir (brand name Rukobia) Integrase strand transfer inhibitors (INSTIs): dolutegravir

ViiV Healthcare

ViiV_Healthcare

Entry inhibitor

Antiviral drug

and prevents the viral transmission that occurs via cell-cell fusion. Fostemsavir, an attachment inhibitor that interferes with the interaction of CD4

Entry inhibitor

Entry_inhibitor

Envelope glycoprotein GP120

Glycoprotein exposed on the surface of the HIV virus

extremely difficult due to its high degree of variability and shielding. Fostemsavir (BMS-663068) is a methyl phosphate prodrug of the small molecule inhibitor

Envelope glycoprotein GP120

Envelope_glycoprotein_GP120

Dapivirine Ring

Antiretroviral vaginal ring

Cenicriviroc†, Leronlimab†) CD4 (Ibalizumab (IBA), Semzuvolimab§) gp120 (Fostemsavir (FTR)) Integrase inhibitors (Integrase strand transfer inhibitors (INSTI))

Dapivirine Ring

Dapivirine_Ring

ATC code J05

Pharmaceutical drug classification

marboxil J05AX26 Amenamevir J05AX27 Favipiravir J05AX28 Bulevirtide J05AX29 Fostemsavir J05AX31 Lenacapavir J05AX32 Riamilovir J05AX33 Labuvirtide "ATC (Anatomical

ATC code J05

ATC_code_J05

List of drugs granted breakthrough therapy designation

carcinoma Inebilizumab Viela Bio neuromyelitis optica spectrum disorder Fostemsavir Viiv Healthcare multidrug-resistant HIV-1 Tafasitamab MorphoSys relapsed

List of drugs granted breakthrough therapy designation

List_of_drugs_granted_breakthrough_therapy_designation

Cabotegravir/rilpivirine

Co-packaged antiretroviral medication

Cenicriviroc†, Leronlimab†) CD4 (Ibalizumab (IBA), Semzuvolimab§) gp120 (Fostemsavir (FTR)) Integrase inhibitors (Integrase strand transfer inhibitors (INSTI))

Cabotegravir/rilpivirine

Semzuvolimab

Experimental antibody for HIV treatment

Cenicriviroc†, Leronlimab†) CD4 (Ibalizumab (IBA), Semzuvolimab§) gp120 (Fostemsavir (FTR)) Integrase inhibitors (Integrase strand transfer inhibitors (INSTI))

Semzuvolimab